Viking Therapeutics, Inc. (LON:0VQA)

Viking Therapeutics Statistics

Total Valuation

LON:0VQA has a market cap or net worth of GBP 3.32 billion. The enterprise value is 2.72 billion.

Market Cap	3.32B
Enterprise Value	2.72B

Important Dates

The last earnings date was Wednesday, July 23, 2025.

Earnings Date	Jul 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	112.44M
Shares Outstanding	n/a
Shares Change (YoY)	+7.91%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	109.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	5.71
P/TBV Ratio	5.71
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-21.72
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 25.86, with a Debt / Equity ratio of 0.00.

Current Ratio	25.86
Quick Ratio	25.26
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2,217.06

Financial Efficiency

Return on equity (ROE) is -19.99% and return on invested capital (ROIC) is -15.48%.

Return on Equity (ROE)	-19.99%
Return on Assets (ROA)	-14.99%
Return on Invested Capital (ROIC)	-15.48%
Return on Capital Employed (ROCE)	-26.74%
Revenue Per Employee	n/a
Profits Per Employee	-2.56M
Employee Count	36
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.43% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-34.43%
50-Day Moving Average	30.01
200-Day Moving Average	35.94
Relative Strength Index (RSI)	66.73
Average Volume (20 Days)	15,886

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.69

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-155.35M
Pretax Income	-125.21M
Net Income	-125.21M
EBITDA	n/a
EBIT	-155.35M
Earnings Per Share (EPS)	-1.12

Balance Sheet

The company has 589.56 million in cash and 640,852 in debt, giving a net cash position of 588.92 million.

Cash & Cash Equivalents	589.56M
Total Debt	640,852
Net Cash	588.92M
Net Cash Per Share	n/a
Equity (Book Value)	580.61M
Book Value Per Share	5.17
Working Capital	580.30M

Cash Flow

Operating Cash Flow	-111.34M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:0VQA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.91%
Shareholder Yield	n/a
Earnings Yield	-3.78%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1